UrexBiotech Report issue

For profit Phase 1
Founded: London ON Canada (1988)
Status: Acquired by Chr Hansen (2009)

Organization Overview

First Clinical Trial
2007
NCT00479947
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree